Developing innovative antiviral treatments.

We specialize in developing treatments focused on cancer and viral diseases.

Advancing antiviral therapies with compounds effective in preclinical and clinical stages.

Rigorous research, particularly in combining conventional treatments with novel compounds for enhanced efficacy.